Assessment Status | Rapid Review complete |
HTA ID | - |
Drug | Ceftaroline |
Brand | Zinforo® |
Indication | For the treatment of adult patients with complicated Skin and Soft Tissue Infections (cSSTI) or Community Acquired Pneumonia (CAP). |
Assessment Process | |
Rapid review commissioned | 08/10/2012 |
Rapid review completed | 12/10/2012 |
Rapid review outcome | Full pharmacoeconomic evaluation not recommended for HCV genotype 3 infection |